Life Science Analytics (LSA)

Overview

Life Science Analytics is a biomedical data company that provides corporate intelligence and research products to life science companies and financial industry professionals. Business development officers, librarians and executives of biomedical companies, as well as vendors and consultants who serve those companies, turn to LSA for their corporate intelligence projects.

Note: LSA reports are prepared by Life Science Analytics (LSA) analysts using data from MedTRACK, a proven competitive intelligence source for the life sciences.

Our Products

Financial Reports
These reports contain the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues.

Each report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally each report includes quarterly book value per share vs. share price. Much of the information contained in each report is included in both tabular and graphic formats.

Product Pipeline Reports
Each report contains: Business Summary; Contact Information; Selected Financial Data; Company Details; Product Glance (Table/Graph); Disease Hub Classification (Table/Graph); Product Pipeline; Product Catalog; Product Details with Description; Therapeutic Indication; Drug Class; Mechanism of Action; Current Trial; Trial Details; Partnering Details etc; Patent Details (if any); Recent Financings; Trademarks; Deals & Alliances; Management Profile; Recent Updates

Competitor Reports
These report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. Each report also includes recent company news updates

Deals & Alliances Reports
Each report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product, technology, miscellaneous), stage of development, list of partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where disclosed, partners in other non-product, non-technology deals, with detailed descriptions of the partner firm and terms when available. Each report also includes M&A statistics and recent partnering news updates by date.

Life Science Analytics (LSA)
 

List of reports from Life Science Analytics (LSA)

3  4  5  6    8    10  11  12  
Xenon Pharma-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides a ...  |  read more...
$750.00
Xenon Pharmaceuticals Inc.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
Xention Limited (formerly Xention Discovery Ltd)-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... accurate, current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. ...  |  read more...
$750.00
Xepa-Soul Pattinson (Malaysia) Sdn Bhd-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each ...  |  read more...
$750.00
Yaupon Therapeutics, Inc.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
Yes Biotech Laboratories Ltd.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report ...  |  read more...
$750.00
YM BioSciences Australia Pty Ltd. (formerly Cytopia Ltd.)-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... reports Accessing accurate, current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 ...  |  read more...
$750.00
YOOYOUNG Pharmaceutical Co., Ltd.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report ...  |  read more...
$750.00
Yuhan Corporation-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides a ...  |  read more...
$750.00
YuSheng Pharmaceutical Co.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
Yuyu Pharma, Inc.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
Zacharon Pharmaceuticals, Inc.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
Zahravi Pharmaceutical Company-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
ZeaVision, LLC-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides a ...  |  read more...
$750.00
Zelos Therapeutics, Inc.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides ...  |  read more...
$750.00
Zhejiang BetaPharma Co., Ltd.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report ...  |  read more...
$750.00
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each ...  |  read more...
$750.00
Zosano Pharma, Inc. (formerly The Macroflux Corporation)-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... Accessing accurate, current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such ...  |  read more...
$750.00
Zydus Pharmaceuticals (USA) Inc.-Detailed Product Pipeline
3/14/2011 | published by: Life Science Analytics (LSA)
... and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report ...  |  read more...
$750.00
Accentia Biopharmaceuticals Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Abbott Laboratories-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
ACADIA Pharmaceuticals Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Tamir Biotechnology, Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
Alcon Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  read more...
$350.00
Acorda Therapeutics Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  read more...
$350.00
3  4  5  6    8    10  11  12  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!